top of page

news & insights

Market Access Insights
Belgium

As market access consultants in Belgium, based in Ghent and working across the Benelux, Axes Health helps international pharma and biotech companies navigate that landscape from early strategy through reimbursement and beyond. These insights explains how the Belgian market access system actually works, what changed in 2026, and how the right approach turns a complex process into a predictable pathway to patients.

Rare Diseases Forum 2026 - because breakthroughs only matter if they reach the patients who need them

Rare Diseases Forum 2026: Innovation & Access

Rare Diseases Forum 2026 - because breakthroughs only matter if they reach the patients who need them

Early access programmes make it possible to start an innovative treatment earlier in case of a clear medical need.

Innovation Access Programs

Early access programmes make it possible to start an innovative treatment earlier in case of a clear medical need.

Modernisation of Reimbursement Procedures in Belgium

Belgium Reimbursement Reform

Modernisation of Reimbursement Procedures in Belgium

Joint Clinical Assessment: bridging European assessment with national patient access solutions

JCA Solutions for European HTA

Joint Clinical Assessment: bridging European assessment with national patient access solutions

strategic insights

As market access consultants in Belgium, based in Ghent and working across the Benelux, Axes Health helps international pharma and biotech companies navigate that landscape from early strategy through reimbursement and beyond. This guide explains how the Belgian market access system actually works, what changed in 2026, and how the right approach turns a complex process into a predictable pathway to patients.

bottom of page